Gene therapy for the treatment of mitochondrial DNA disorders.
Despite recent epidemiological studies confirming that mitochondrial respiratory chain disorders due to mutations in either the mitochondrial or nuclear genome are amongst the most common inherited human diseases, realistic therapeutic strategies for these patients remain limited. The disappointing response to various vitamins, cofactors and electron acceptors that have been administered to patients in an attempt to bypass the underlying respiratory chain defect, coupled with the complexities of human mitochondrial genetics, means that novel and innovative means are required to offer realistic treatments. Several 'gene therapy' strategies have therefore been proposed to treat patients with pathogenic mitochondrial DNA mutations, and although these are not without their own inherent problems, several exciting approaches promise much in the near future. This review will provide a basic background to mitochondrial genetics and mitochondrial DNA disorders before introducing the various strategies being tested in vitro at present, in cell culture and animal models, and, in the example of therapeutic exercise, in patients themselves.
Taylor
Robert W
RW
University of Newcastle upon Tyne, Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, Newcastle upon Tyne, NE2 4HH, UK. r.w.taylor@ncl.ac.uk
D000818:Animals; D004272:DNA, Mitochondrial / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D028361:Mitochondrial Diseases / Q000235:genetics* / Q000628:therapy
D004272:DNA, Mitochondrial